PM: decision on the application for modification of an agreed PIP
Decision date
Decision
P/0065/2022 : EMA decision of 11 March 2022 on the acceptance of a modification of an agreed paediatric investigation plan for guselkumab (Tremfya), (EMEA-001523-PIP05-19-M01)